Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-11-058751
Filing Date
2011-12-22
Accepted
2011-12-22 16:44:42
Documents
1
Period of Report
2011-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 8512
  Complete submission text file 0001140361-11-058751.txt   10296
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 333-176897 | Film No.: 111277981